학술논문
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma® ) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System
Document Type
Article
Author
Source
In: Pharmaceuticals . (Pharmaceuticals, March 2024, 17(3))
Subject
Language
English
ISSN
14248247